Multidisciplinary Perspectives of Challenges in Infective Endocarditis Complicated by Septic Embolic-Induced Acute Myocardial Infarction DOI Creative Commons
Elena Stamate, Oana Roxana Ciobotaru, Manuela Arbune

и другие.

Antibiotics, Год журнала: 2024, Номер 13(6), С. 513 - 513

Опубликована: Май 31, 2024

Background: Infective endocarditis (IE) management is challenging, usually requiring multidisciplinary collaboration from cardiologists, infectious disease specialists, interventional and cardiovascular surgeons, as more than half of the cases will require surgical procedures. Therefore, it essential for all healthcare providers involved in managing IE to understand disease’s characteristics, potential complications, treatment options. While systemic embolization one most frequent complications IE, coronary localization emboli causing acute myocardial infarction (AMI) less common, with an incidence ranging 1% 10% cases, but has a much higher rate morbidity mortality. There are no guidelines this type AMI IE. Methods: This narrative review summarizes current knowledge regarding septic patients Additionally, paper highlights diagnosis challenges such particularly due lack protocols or consensus field. Results: Data extracted case reports indicate that often occurs within first two weeks disease. The aortic valve commonly vegetation, occluded vessel frequently left anterior descending artery. Broad-spectrum antibiotic therapy followed by targeted infection control essential, offers promising results through embolectomy, concomitant replacement aspiration thrombectomy, without subsequent stent insertion. Thrombolytics be avoided increased risk bleeding. Conclusions: All these aspects should constitute future lines research, allowing integration team studies on larger patient cohorts and, subsequently, creating assessing guiding potentially fatal complication.

Язык: Английский

Benchmarking antimicrobial use to antimicrobial resistance: a comparative study of two hospitals using current National Healthcare Safety Network (NHSN) metrics DOI
Carlos A.Q. Santos, Sarah Won,

Ryan Dwyer

и другие.

Infection Control and Hospital Epidemiology, Год журнала: 2025, Номер unknown, С. 1 - 8

Опубликована: Янв. 27, 2025

Abstract Objective: We aimed to determine whether benchmarking antimicrobial use (AU) resistance (AR) using select AU/AR ratios is more informative than AU metrics in isolation. Design: retrospectively measured (antimicrobial therapy days per 1,000 present) and (specific corresponding AR event) two hospitals during 2020 through 2022. then had stewardship committee members evaluate each value indicate they believed it represented potential overuse, appropriate use, or underuse of the antimicrobials, could not provide an assessment. Setting: Two acute-care hospitals. Patients: Hospitalized patients. Results: In semi-annual facility-wide analyses, echinocandins a median ratio 658.5 fluconazole-resistant Candida event Hospital A, IV vancomycin 114.9 108.2 methicillin-resistant Staphylococcus aureus A B, respectively, linezolid 33.8 88.0 vancomycin-resistant Enterococcus respectively. When values were evaluated by committees, respondents able assess based on compared values. Based ratios, most identified overuse B. Conclusion: Select provided personnel, which can be used motivate audits administration appropriateness.

Язык: Английский

Процитировано

0

Diagnosis of Coxiella burnetii endocarditis by using nanopore targeted sequencing: a case report DOI Creative Commons
Xinsheng Yan,

Qimei Wei,

Tingting Liu

и другие.

BMC Infectious Diseases, Год журнала: 2025, Номер 25(1)

Опубликована: Фев. 5, 2025

Язык: Английский

Процитировано

0

Moving from intravenous to per os in the treatment of endocarditis: Time to switch to better branding DOI Creative Commons
Emily G. McDonald

CMI Communications, Год журнала: 2025, Номер unknown, С. 105068 - 105068

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

The Evolving Landscape of Infective Endocarditis: Difficult-to-Treat Resistance Bacteria and Novel Diagnostics at the Foreground DOI Open Access

Vasiliki Rapti,

Efthymia Giannitsioti, Nikolaos Spernovasilis

и другие.

Journal of Clinical Medicine, Год журнала: 2025, Номер 14(6), С. 2087 - 2087

Опубликована: Март 19, 2025

Infective endocarditis (IE) is a relatively rare but potentially life-threatening disease characterized by substantial mortality and long-term sequelae among the survivors. In recent decades, dramatic change in profile of patients diagnosed with IE has been observed primarily developed countries, most likely due to an aging population increase invasive medical procedures. Nowadays, typical patient usually older, complex comorbidities, history significant for cardiac disease, including degenerative heart valve prosthetic valves, or cardiovascular implantable electronic devices (CIEDs). Moreover, as risk factors change, predisposing them more healthcare-associated IE, microbiology also shifting; there are growing concerns regarding rise incidence caused difficult-to-treat resistance (DTR) bacteria at-risk frequent healthcare contact. The present review aims explore evolving landscape summarize current knowledge on novel diagnostics ensure timely diagnosis outline optimal therapy DTR bacterial IE.

Язык: Английский

Процитировано

0

From Heart to Eye DOI Creative Commons
María José Santa-Ana-Bayona,

Gilberto H. Acosta-Gutiérrez,

Pavel Martinez‐Dominguez

и другие.

JACC Case Reports, Год журнала: 2025, Номер 30(6), С. 103299 - 103299

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Management of methicillin-resistant staphylococcus aureus bloodstream infections: a comprehensive narrative review of available evidence focusing on current controversies and the challenges ahead DOI
Alberto Enrico Maraolo, Milo Gatti, Luigi Principe

и другие.

Expert Review of Anti-infective Therapy, Год журнала: 2025, Номер unknown

Опубликована: Март 31, 2025

Bloodstream infections (BSIs) caused by Staphylococcus aureus are common worldwide, representing one of the most relevant issues in clinical infectious diseases practice. In particular, BSIs methicillin-resistant S. (MRSA-BSI) still today a challenge since mortality burden remains elevated although decades research. The following topics regarding MRSA-BSI were reviewed and discussed resorting to best available evidence retrieved from PubMed/MEDLINE up October 2024: i) epidemiology; ii) microbiology; iii) classification, with focus on complicated not forms; iv) structured approach patient; v) pharmacokinetics pharmacodynamics main antimicrobial options; vi) controversies therapeutic approach. Despite ongoing efforts better stratify manage MRSA-BSI, there is no universally accepted classification system accurately distinguishing between uncomplicated/low risk complicated/high forms. Biomarkers such as interleukin(IL)-10 hold promise order enable more precise stratification, premise for an appropriate treatment plan. There theoretical rationale implementing combination therapy including beta-lactam agent upfront, especially patients considered at higher unfavorable outcomes, but further data necessary, same applies newer adjuvants. Novel microbiological techniques may help guiding duration.

Язык: Английский

Процитировано

0

Clinical applications of artificial intelligence and machine learning in neurocardiology: a comprehensive review DOI Creative Commons
Jade Basem, Racheed Mani,

Scott Sun

и другие.

Frontiers in Cardiovascular Medicine, Год журнала: 2025, Номер 12

Опубликована: Апрель 3, 2025

Neurocardiology is an evolving field focusing on the interplay between nervous system and cardiovascular that can be used to describe understand many pathologies. Acute ischemic stroke understood through this framework of interconnected, reciprocal relationship such occurs secondary cardiac pathology (the Heart-Brain axis), injury various neurological disease processes Brain-Heart axis). The timely assessment, diagnosis, subsequent management cerebrovascular diseases essential part bettering patient outcomes progression medicine. Artificial intelligence (AI) machine learning (ML) are robust areas research aid diagnostic accuracy clinical decision making better manage neurocardiology. In review, we identify some widely utilized upcoming AI/ML algorithms for most common sources stroke, strokes undetermined etiology, stroke. We found numerous highly accurate efficient products that, when integrated, provided improved efficacy prediction, identification, prognosis, within sphere focus cryptogenic strokes, there promising elucidating likely underlying causes thus, treatment options prevention. While still require a larger knowledge base or manual algorithmic training, in neurocardiology has potential provide more comprehensive healthcare treatment, increase access equitable healthcare, improve outcomes. Our review shows evident interest exciting new frontier with artificial learning.

Язык: Английский

Процитировано

0

Which trial do we need? Ampicillin versus ampicillin plus ceftriaxone for E. faecalis endocarditis: is it time to start re-considering monotherapy? DOI
Emanuele Rando, Jesús Rodríguez‐Baño,

Luis Eduardo López Cortés

и другие.

Clinical Microbiology and Infection, Год журнала: 2025, Номер unknown

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

A preliminary retrospective study of the safety of Vancomycin area under the curve in patients treated with concomitant use of Vancomycin and gentamicin DOI Creative Commons
Hirokazu Nakayama, Yoshitsugu Nakamura,

Masayo Tanaka

и другие.

Journal of Pharmaceutical Health Care and Sciences, Год журнала: 2025, Номер 11(1)

Опубликована: Апрель 14, 2025

Abstract Background Despite numerous studies on safety, acute kidney injury (AKI) caused by vancomycin and/or gentamicin remains a persistent medical issue. However, it unclear whether AUC below 600 mg·h/L in combination with trough level at least 2 µg/mL are reliable indices to reduce the risk of AKI patients treated concomitant and gentamicin. Objective The aim was elucidate pharmacokinetic factors associated development receiving use setting therapeutic drug monitoring (TDM). Methods A retrospective study conducted 15 TDM. were classified into group no-AKI group. Vancomycin area under curve (AUC), levels, duration investigated. Results Six (40%) developed during period. In ( n = 6), significant higher [median (range) 561 (543‒712) compared 9), 380 (185‒600) mg·h/L, p 0.026)], although no differences treatment found between two groups. Receiver operating characteristic analysis showed that best cut-off for predicting 523 0.852, sensitivity 1.000 specificity 0.778 0.025). Conclusions 1–2 µg/mL, 530 − is risk.

Язык: Английский

Процитировано

0

Infective Endocarditis DOI
Emily Abdoler, Emily Stoneman

Oxford University Press eBooks, Год журнала: 2025, Номер unknown, С. 371 - 376

Опубликована: Апрель 1, 2025

Abstract This chapter guides the reader on diagnosis and management of infective endocarditis in hospitalized patients.

Язык: Английский

Процитировано

0